Advertisement

Index by author

September 01, 2013; Volume 346,Issue 3

A

  1. Ahnaou, Abdel

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  2. Akcay, Ali

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  3. Amant, Frédéric

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  4. Andrés, Jose Ignacio

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  5. Arnaud, Claire

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

  6. Atack, John R.

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  7. Augustin, Ewa

    1. DNA-Damaging Imidazoacridinone C-1311 Induces Autophagy followed by Irreversible Growth Arrest and Senescence in Human Lung Cancer Cells
      Joanna Polewska, Anna Skwarska, Ewa Augustin and Jerzy Konopa
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 393-405; DOI: https://doi.org/10.1124/jpet.113.203851

B

  1. Bashir, Tarig

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

  2. Beijnen, Jos H.

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Gene Dosage on Plasma Pharmacokinetics and Brain Accumulation of Dasatinib, Sorafenib, and Sunitinib
      Seng Chuan Tang, Niels de Vries, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 486-494; DOI: https://doi.org/10.1124/jpet.113.205583

  3. Berraondo, Pedro

    1. Modeling Tumor Response after Combined Administration of Different Immune-Stimulatory Agents
      Zinnia P. Parra-Guillen, Pedro Berraondo, Benjamin Ribba and Iñaki F. Trocóniz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 432-442; DOI: https://doi.org/10.1124/jpet.113.206961

  4. Biesmans, Ilse

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  5. Bjorklund, Chad C.

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

  6. Blaise, Sophie

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

  7. Bousquet, Pascal

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  8. Boutonnat, Jean

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

  9. Brents, Lisa K.

    1. Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy
      Lisa K. Brents, Sarah M. Zimmerman, Amanda R. Saffell, Paul L. Prather and William E. Fantegrossi
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 350-361; DOI: https://doi.org/10.1124/jpet.113.206003

C

  1. Cabral, José Miguel

    1. Short- and Long-Term Regulation of Intestinal Na+/H+ Exchange Activity Associated with TLR2 Receptor Activation Is Independent of Nuclear Factor-κB Signaling
      José Miguel Cabral, Patrício Soares-da-Silva and Fernando Magro
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 453-464; DOI: https://doi.org/10.1124/jpet.113.204602

  2. Calzetta, Luigino

    1. Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone
      Luigino Calzetta, Clive P. Page, Domenico Spina, Mario Cazzola, Paola Rogliani, Francesco Facciolo and Maria Gabriella Matera
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 414-423; DOI: https://doi.org/10.1124/jpet.113.204644

  3. Cazzola, Mario

    1. Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone
      Luigino Calzetta, Clive P. Page, Domenico Spina, Mario Cazzola, Paola Rogliani, Francesco Facciolo and Maria Gabriella Matera
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 414-423; DOI: https://doi.org/10.1124/jpet.113.204644

  4. Chetrite, Gérard

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  5. Cid, Jose Maria

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  6. Cracowski, Jean-Luc

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

D

  1. Dautzenberg, Frank M.

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  2. Debiève, Frédéric

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  3. De Vos, Rita

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  4. de Vries, Niels

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Gene Dosage on Plasma Pharmacokinetics and Brain Accumulation of Dasatinib, Sorafenib, and Sunitinib
      Seng Chuan Tang, Niels de Vries, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 486-494; DOI: https://doi.org/10.1124/jpet.113.205583

  5. Drinkenburg, Wilhelmus

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

E

  1. Edelstein, Charles L.

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

F

  1. Facciolo, Francesco

    1. Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone
      Luigino Calzetta, Clive P. Page, Domenico Spina, Mario Cazzola, Paola Rogliani, Francesco Facciolo and Maria Gabriella Matera
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 414-423; DOI: https://doi.org/10.1124/jpet.113.204644

  2. Fantegrossi, William E.

    1. Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy
      Lisa K. Brents, Sarah M. Zimmerman, Amanda R. Saffell, Paul L. Prather and William E. Fantegrossi
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 350-361; DOI: https://doi.org/10.1124/jpet.113.206003

  3. Fellmann, Lyne

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  4. Fève, Bruno

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

G

  1. Ganno, Michelle L.

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  2. Gasior, Maciej

    1. Long-Lasting Attenuation of Amygdala-Kindled Seizures after Convection-Enhanced Delivery of Botulinum Neurotoxins A and B into the Amygdala in Rats
      Maciej Gasior, Rebecca Tang and Michael A. Rogawski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 528-534; DOI: https://doi.org/10.1124/jpet.113.205070

  3. Gasparik, Vincent

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  4. Giembycz, Mark A.

    1. Concurrent Agonism of Adenosine A2B and Glucocorticoid Receptors in Human Airway Epithelial Cells Cooperatively Induces Genes with Anti-Inflammatory Potential: A Novel Approach to Treat Chronic Obstructive Pulmonary Disease
      Stephanie Greer, Cara W. Page, Taruna Joshi, Dong Yan, Robert Newton and Mark A. Giembycz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 473-485; DOI: https://doi.org/10.1124/jpet.113.206284

  5. Gigou, Luc

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  6. Godin-Ribuot, Diane

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

  7. Greer, Stephanie

    1. Concurrent Agonism of Adenosine A2B and Glucocorticoid Receptors in Human Airway Epithelial Cells Cooperatively Induces Genes with Anti-Inflammatory Potential: A Novel Approach to Treat Chronic Obstructive Pulmonary Disease
      Stephanie Greer, Cara W. Page, Taruna Joshi, Dong Yan, Robert Newton and Mark A. Giembycz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 473-485; DOI: https://doi.org/10.1124/jpet.113.206284

  8. Greney, Hugues

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  9. Gu, Dongmin

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

  10. Gziri, Mina Mhallem

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

H

  1. He, Zhibin

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

I

  1. Iwasaki, Fumiyoshi

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

J

  1. Jani, Alkesh

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  2. Janssens, Stefan P.

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  3. Jones, Richard J.

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

  4. Joshi, Taruna

    1. Concurrent Agonism of Adenosine A2B and Glucocorticoid Receptors in Human Airway Epithelial Cells Cooperatively Induces Genes with Anti-Inflammatory Potential: A Novel Approach to Treat Chronic Obstructive Pulmonary Disease
      Stephanie Greer, Cara W. Page, Taruna Joshi, Dong Yan, Robert Newton and Mark A. Giembycz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 473-485; DOI: https://doi.org/10.1124/jpet.113.206284

  5. Julien, Claude

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

K

  1. Kim, Hyun-Jung

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  2. Konopa, Jerzy

    1. DNA-Damaging Imidazoacridinone C-1311 Induces Autophagy followed by Irreversible Growth Arrest and Senescence in Human Lung Cancer Cells
      Joanna Polewska, Anna Skwarska, Ewa Augustin and Jerzy Konopa
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 393-405; DOI: https://doi.org/10.1124/jpet.113.203851

  3. Kotzki, Sylvain

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

  4. Kuiatse, Isere

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

L

  1. Labuz, Dominika

    1. Stronger Antinociceptive Efficacy of Opioids at the Injured Nerve Trunk Than at Its Peripheral Terminals in Neuropathic Pain
      Dominika Labuz and Halina Machelska
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 535-544; DOI: https://doi.org/10.1124/jpet.113.205344

  2. Lacolley, Patrick

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  3. Langlois, Xavier

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  4. Lavreysen, Hilde

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  5. Lee, Dong Won

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  6. Ljubanovic, Danica

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  7. Lütjens, Robert

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

M

  1. Macdonald, Gregor

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  2. Machelska, Halina

    1. Stronger Antinociceptive Efficacy of Opioids at the Injured Nerve Trunk Than at Its Peripheral Terminals in Neuropathic Pain
      Dominika Labuz and Halina Machelska
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 535-544; DOI: https://doi.org/10.1124/jpet.113.205344

  3. Magro, Fernando

    1. Short- and Long-Term Regulation of Intestinal Na+/H+ Exchange Activity Associated with TLR2 Receptor Activation Is Independent of Nuclear Factor-κB Signaling
      José Miguel Cabral, Patrício Soares-da-Silva and Fernando Magro
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 453-464; DOI: https://doi.org/10.1124/jpet.113.204602

  4. Martínez-Guerrero, Lucy J.

    1. Substrate-Dependent Inhibition of Human MATE1 by Cationic Ionic Liquids
      Lucy J. Martínez-Guerrero and Stephen H. Wright
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 495-503; DOI: https://doi.org/10.1124/jpet.113.204206

  5. Matera, Maria Gabriella

    1. Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone
      Luigino Calzetta, Clive P. Page, Domenico Spina, Mario Cazzola, Paola Rogliani, Francesco Facciolo and Maria Gabriella Matera
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 414-423; DOI: https://doi.org/10.1124/jpet.113.204644

  6. Matsui, Tetsuo

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

  7. Max, Jean-Pierre

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  8. McLaughlin, Jay P.

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  9. Megens, Anton

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  10. Mertens, Luc

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  11. Minotti, Giorgio

    1. Pharmacology at Work for Cardio-Oncology: Ranolazine to Treat Early Cardiotoxicity Induced by Antitumor Drugs
      Giorgio Minotti
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 343-349; DOI: https://doi.org/10.1124/jpet.113.204057

  12. Minoura, Hideaki

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

  13. Morris, Marilyn E.

    1. Toxicokinetics/Toxicodynamics of γ-Hydroxybutyrate-Ethanol Intoxication: Evaluation of Potential Treatment Strategies
      Bridget L. Morse and Marilyn E. Morris
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 504-513; DOI: https://doi.org/10.1124/jpet.113.206250

  14. Morse, Bridget L.

    1. Toxicokinetics/Toxicodynamics of γ-Hydroxybutyrate-Ethanol Intoxication: Evaluation of Potential Treatment Strategies
      Bridget L. Morse and Marilyn E. Morris
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 504-513; DOI: https://doi.org/10.1124/jpet.113.206250

  15. Muscat, Adeline

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

N

  1. Negoro, Kenji

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

  2. Newton, Robert

    1. Concurrent Agonism of Adenosine A2B and Glucocorticoid Receptors in Human Airway Epithelial Cells Cooperatively Induces Genes with Anti-Inflammatory Potential: A Novel Approach to Treat Chronic Obstructive Pulmonary Disease
      Stephanie Greer, Cara W. Page, Taruna Joshi, Dong Yan, Robert Newton and Mark A. Giembycz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 473-485; DOI: https://doi.org/10.1124/jpet.113.206284

  3. Nguyen, Quocan

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  4. Niederhoffer, Nathalie

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

O

  1. O. Keys, Daniel

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  2. Oréa, Valérie

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  3. Orlowski, Robert Z.

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

  4. Oshima, Hiroyuki

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

P

  1. Page, Cara W.

    1. Concurrent Agonism of Adenosine A2B and Glucocorticoid Receptors in Human Airway Epithelial Cells Cooperatively Induces Genes with Anti-Inflammatory Potential: A Novel Approach to Treat Chronic Obstructive Pulmonary Disease
      Stephanie Greer, Cara W. Page, Taruna Joshi, Dong Yan, Robert Newton and Mark A. Giembycz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 473-485; DOI: https://doi.org/10.1124/jpet.113.206284

  2. Page, Clive P.

    1. Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone
      Luigino Calzetta, Clive P. Page, Domenico Spina, Mario Cazzola, Paola Rogliani, Francesco Facciolo and Maria Gabriella Matera
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 414-423; DOI: https://doi.org/10.1124/jpet.113.204644

  3. Parra-Guillen, Zinnia P.

    1. Modeling Tumor Response after Combined Administration of Different Immune-Stimulatory Agents
      Zinnia P. Parra-Guillen, Pedro Berraondo, Benjamin Ribba and Iñaki F. Trocóniz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 432-442; DOI: https://doi.org/10.1124/jpet.113.206961

  4. Patkar, Kshitij A.

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  5. Peeters, Luc

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  6. Pizard, Anne

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  7. Pokreisz, Peter

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  8. Polewska, Joanna

    1. DNA-Damaging Imidazoacridinone C-1311 Induces Autophagy followed by Irreversible Growth Arrest and Senescence in Human Lung Cancer Cells
      Joanna Polewska, Anna Skwarska, Ewa Augustin and Jerzy Konopa
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 393-405; DOI: https://doi.org/10.1124/jpet.113.203851

  9. Prather, Paul L.

    1. Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy
      Lisa K. Brents, Sarah M. Zimmerman, Amanda R. Saffell, Paul L. Prather and William E. Fantegrossi
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 350-361; DOI: https://doi.org/10.1124/jpet.113.206003

R

  1. Rais, Rana

    1. Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
      James J. Vornov, Krystyna M. Wozniak, Ying Wu, Camilo Rojas, Rana Rais and Barbara S. Slusher
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 406-413; DOI: https://doi.org/10.1124/jpet.113.205039

  2. Rasakham, Khampaseuth

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  3. Ravichandran, Kameswaran

    1. NLRP3 Inflammasome Knockout Mice Are Protected against Ischemic but Not Cisplatin-Induced Acute Kidney Injury
      Hyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, Daniel O. Keys, Ali Akcay, Quocan Nguyen, Zhibin He, Alkesh Jani, Danica Ljubanovic and Charles L. Edelstein
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 465-472; DOI: https://doi.org/10.1124/jpet.113.205732

  4. Regnault, Véronique

    1. A New Pyrroline Compound Selective for I1-Imidazoline Receptors Improves Metabolic Syndrome in Rats
      Lyne Fellmann, Véronique Regnault, Hugues Greney, Vincent Gasparik, Adeline Muscat, Jean-Pierre Max, Luc Gigou, Valérie Oréa, Gérard Chetrite, Anne Pizard, Nathalie Niederhoffer, Claude Julien, Patrick Lacolley, Bruno Fève and Pascal Bousquet
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 370-380; DOI: https://doi.org/10.1124/jpet.113.205328

  5. Remaley, Alan T.

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

  6. Ribba, Benjamin

    1. Modeling Tumor Response after Combined Administration of Different Immune-Stimulatory Agents
      Zinnia P. Parra-Guillen, Pedro Berraondo, Benjamin Ribba and Iñaki F. Trocóniz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 432-442; DOI: https://doi.org/10.1124/jpet.113.206961

  7. Rogawski, Michael A.

    1. Long-Lasting Attenuation of Amygdala-Kindled Seizures after Convection-Enhanced Delivery of Botulinum Neurotoxins A and B into the Amygdala in Rats
      Maciej Gasior, Rebecca Tang and Michael A. Rogawski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 528-534; DOI: https://doi.org/10.1124/jpet.113.205070

  8. Rogliani, Paola

    1. Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone
      Luigino Calzetta, Clive P. Page, Domenico Spina, Mario Cazzola, Paola Rogliani, Francesco Facciolo and Maria Gabriella Matera
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 414-423; DOI: https://doi.org/10.1124/jpet.113.204644

  9. Rojas, Camilo

    1. Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
      James J. Vornov, Krystyna M. Wozniak, Ying Wu, Camilo Rojas, Rana Rais and Barbara S. Slusher
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 406-413; DOI: https://doi.org/10.1124/jpet.113.205039

  10. Ross, Nicolette C.

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  11. Roustit, Matthieu

    1. Anodal Iontophoresis of a Soluble Guanylate Cyclase Stimulator Induces a Sustained Increase in Skin Blood Flow in Rats
      Sylvain Kotzki, Matthieu Roustit, Claire Arnaud, Jean Boutonnat, Sophie Blaise, Diane Godin-Ribuot and Jean-Luc Cracowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 424-431; DOI: https://doi.org/10.1124/jpet.113.205484

S

  1. Saffell, Amanda R.

    1. Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy
      Lisa K. Brents, Sarah M. Zimmerman, Amanda R. Saffell, Paul L. Prather and William E. Fantegrossi
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 350-361; DOI: https://doi.org/10.1124/jpet.113.206003

  2. Sakuda, Shuichi

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

  3. Schinkel, Alfred H.

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Gene Dosage on Plasma Pharmacokinetics and Brain Accumulation of Dasatinib, Sorafenib, and Sunitinib
      Seng Chuan Tang, Niels de Vries, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 486-494; DOI: https://doi.org/10.1124/jpet.113.205583

  4. Shibasaki, Masayuki

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

  5. Singh, Harminder D.

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  6. Skwarska, Anna

    1. DNA-Damaging Imidazoacridinone C-1311 Induces Autophagy followed by Irreversible Growth Arrest and Senescence in Human Lung Cancer Cells
      Joanna Polewska, Anna Skwarska, Ewa Augustin and Jerzy Konopa
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 393-405; DOI: https://doi.org/10.1124/jpet.113.203851

  7. Slusher, Barbara S.

    1. Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
      James J. Vornov, Krystyna M. Wozniak, Ying Wu, Camilo Rojas, Rana Rais and Barbara S. Slusher
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 406-413; DOI: https://doi.org/10.1124/jpet.113.205039

  8. Soares-da-Silva, Patrício

    1. Short- and Long-Term Regulation of Intestinal Na+/H+ Exchange Activity Associated with TLR2 Receptor Activation Is Independent of Nuclear Factor-κB Signaling
      José Miguel Cabral, Patrício Soares-da-Silva and Fernando Magro
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 453-464; DOI: https://doi.org/10.1124/jpet.113.204602

  9. Sparidans, Rolf W.

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Gene Dosage on Plasma Pharmacokinetics and Brain Accumulation of Dasatinib, Sorafenib, and Sunitinib
      Seng Chuan Tang, Niels de Vries, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 486-494; DOI: https://doi.org/10.1124/jpet.113.205583

  10. Spina, Domenico

    1. Effect of the Mixed Phosphodiesterase 3/4 Inhibitor RPL554 on Human Isolated Bronchial Smooth Muscle Tone
      Luigino Calzetta, Clive P. Page, Domenico Spina, Mario Cazzola, Paola Rogliani, Francesco Facciolo and Maria Gabriella Matera
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 414-423; DOI: https://doi.org/10.1124/jpet.113.204644

T

  1. Tanaka, Hirotsugu

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

  2. Tang, Rebecca

    1. Long-Lasting Attenuation of Amygdala-Kindled Seizures after Convection-Enhanced Delivery of Botulinum Neurotoxins A and B into the Amygdala in Rats
      Maciej Gasior, Rebecca Tang and Michael A. Rogawski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 528-534; DOI: https://doi.org/10.1124/jpet.113.205070

  3. Tang, Seng Chuan

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Gene Dosage on Plasma Pharmacokinetics and Brain Accumulation of Dasatinib, Sorafenib, and Sunitinib
      Seng Chuan Tang, Niels de Vries, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 486-494; DOI: https://doi.org/10.1124/jpet.113.205583

  4. te Riele, Paula

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  5. Toll, Lawrence

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  6. Trabanco, Andrés A.

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  7. Trocóniz, Iñaki F.

    1. Modeling Tumor Response after Combined Administration of Different Immune-Stimulatory Agents
      Zinnia P. Parra-Guillen, Pedro Berraondo, Benjamin Ribba and Iñaki F. Trocóniz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 432-442; DOI: https://doi.org/10.1124/jpet.113.206961

V

  1. Van der Linden, Ilse

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  2. Verbeken, Eric

    1. Fetal Rat Hearts Do Not Display Acute Cardiotoxicity in Response to Maternal Doxorubicin Treatment
      Mina Mhallem Gziri, Peter Pokreisz, Rita De Vos, Eric Verbeken, Frédéric Debiève, Luc Mertens, Stefan P. Janssens and Frédéric Amant
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 362-369; DOI: https://doi.org/10.1124/jpet.113.205419

  3. Vornov, James J.

    1. Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
      James J. Vornov, Krystyna M. Wozniak, Ying Wu, Camilo Rojas, Rana Rais and Barbara S. Slusher
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 406-413; DOI: https://doi.org/10.1124/jpet.113.205039

  4. Vreys, Veronique

    1. The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
      Richard J. Jones, Dongmin Gu, Chad C. Bjorklund, Isere Kuiatse, Alan T. Remaley, Tarig Bashir, Veronique Vreys and Robert Z. Orlowski
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 381-392; DOI: https://doi.org/10.1124/jpet.113.204958

W

  1. Wagenaar, Els

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Gene Dosage on Plasma Pharmacokinetics and Brain Accumulation of Dasatinib, Sorafenib, and Sunitinib
      Seng Chuan Tang, Niels de Vries, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 486-494; DOI: https://doi.org/10.1124/jpet.113.205583

  2. Wintmolders, Cindy

    1. Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782
      Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Ilse Biesmans, Ilse Van der Linden, Luc Peeters, Anton Megens, Cindy Wintmolders, Jose Maria Cid, Andrés A. Trabanco, Jose Ignacio Andrés, Frank M. Dautzenberg, Robert Lütjens, Gregor Macdonald and John R. Atack
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 514-527; DOI: https://doi.org/10.1124/jpet.113.204990

  3. Wozniak, Krystyna M.

    1. Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
      James J. Vornov, Krystyna M. Wozniak, Ying Wu, Camilo Rojas, Rana Rais and Barbara S. Slusher
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 406-413; DOI: https://doi.org/10.1124/jpet.113.205039

  4. Wright, Stephen H.

    1. Substrate-Dependent Inhibition of Human MATE1 by Cationic Ionic Liquids
      Lucy J. Martínez-Guerrero and Stephen H. Wright
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 495-503; DOI: https://doi.org/10.1124/jpet.113.204206

  5. Wu, Jinhua

    1. Physical Presence of Nor-Binaltorphimine in Mouse Brain over 21 Days after a Single Administration Corresponds to Its Long-Lasting Antagonistic Effect on κ-Opioid Receptors
      Kshitij A. Patkar, Jinhua Wu, Michelle L. Ganno, Harminder D. Singh, Nicolette C. Ross, Khampaseuth Rasakham, Lawrence Toll and Jay P. McLaughlin
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 545-554; DOI: https://doi.org/10.1124/jpet.113.206086

  6. Wu, Ying

    1. Pharmacokinetics and Pharmacodynamics of the Glutamate Carboxypeptidase II Inhibitor 2-MPPA Show Prolonged Alleviation of Neuropathic Pain through an Indirect Mechanism
      James J. Vornov, Krystyna M. Wozniak, Ying Wu, Camilo Rojas, Rana Rais and Barbara S. Slusher
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 406-413; DOI: https://doi.org/10.1124/jpet.113.205039

Y

  1. Yamazaki, Takao

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

  2. Yan, Dong

    1. Concurrent Agonism of Adenosine A2B and Glucocorticoid Receptors in Human Airway Epithelial Cells Cooperatively Induces Genes with Anti-Inflammatory Potential: A Novel Approach to Treat Chronic Obstructive Pulmonary Disease
      Stephanie Greer, Cara W. Page, Taruna Joshi, Dong Yan, Robert Newton and Mark A. Giembycz
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 473-485; DOI: https://doi.org/10.1124/jpet.113.206284

  3. Yoshida, Shigeru

    1. Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
      Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466

Z

  1. Zimmerman, Sarah M.

    1. Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy
      Lisa K. Brents, Sarah M. Zimmerman, Amanda R. Saffell, Paul L. Prather and William E. Fantegrossi
      Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 350-361; DOI: https://doi.org/10.1124/jpet.113.206003
Back to top

In this issue